1. Home
  2. PCTY vs PCVX Comparison

PCTY vs PCVX Comparison

Compare PCTY & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paylocity Holding Corporation

PCTY

Paylocity Holding Corporation

HOLD

Current Price

$146.23

Market Cap

7.8B

Sector

Technology

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

N/A

Current Price

$65.96

Market Cap

7.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PCTY
PCVX
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
7.0B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
PCTY
PCVX
Price
$146.23
$65.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
11
Target Price
★ $172.15
$108.67
AVG Volume (30 Days)
564.6K
★ 1.8M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 22.39
N/A
EPS
★ 4.92
N/A
Revenue
★ $1,771,326,000.00
N/A
Revenue This Year
$6.90
N/A
Revenue Next Year
$7.83
N/A
P/E Ratio
$29.93
★ N/A
Revenue Growth
★ 11.04
N/A
52 Week Low
$92.99
$39.87
52 Week High
$161.93
$90.75

Technical Indicators

Market Signals
Indicator
PCTY
PCVX
Relative Strength Index (RSI) 51.99 58.82
Support Level $140.01 $52.91
Resistance Level $148.70 N/A
Average True Range (ATR) 3.82 4.04
MACD 0.04 0.98
Stochastic Oscillator 74.36 30.10

Price Performance

Historical Comparison
PCTY
PCVX

About PCTY Paylocity Holding Corporation

Paylocity is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. With the addition of expense and IT management modules, Paylocity unifies back-office operations spanning HR, finance, and IT on a single platform and bills customers on a subscription basis. The firm's customer base skews toward the midmarket and is primarily based in the US. As of fiscal 2026, Paylocity has nearly 44,400 customers.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: